fbpx
June 10, 2022

Positive Topline Results for Novel Probiotic in Autism Positive Topline Results for Novel Probiotic in Autism

Scioto Biosciences has announced positive topline results from their phase 1b trial evaluating the novel probiotic SB-121 (Lactobacillus reuteri with dextran microparticles and maltose) in individuals […]
June 10, 2022

Children With Mild TBI at Risk for Behavioral and Emotional Problems Children With Mild TBI at Risk for Behavioral and Emotional Problems

The study covered in this summary was published on medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Mild traumatic brain injury […]
June 10, 2022

Appropriate Use of Dose-Adjusted and Low-Intensity DOACs Defined, Urged Appropriate Use of Dose-Adjusted and Low-Intensity DOACs Defined, Urged

NEW YORK (Reuters Health) – When it comes to direct oral anticoagulants (DOACs), dose-adjustment and low-intensity treatment are two different forms of dose reduction, each with […]
June 10, 2022

Stigma in Nonalcoholic Fatty Liver Disease Little Studied Stigma in Nonalcoholic Fatty Liver Disease Little Studied

Nonalcoholic fatty liver disease is a silent condition with limited symptoms in which excess fat accumulates in the liver. Taking the top spot for the most […]
June 10, 2022

Interprofessional Education Benefits Nursing, Medical Students Interprofessional Education Benefits Nursing, Medical Students

Creating opportunities for nursing students and medical students to collaborate during their training can be tricky. Still, research suggests doing so can yield massive payoffs for […]
June 10, 2022

New Advances Transform Treatment of Prostate Cancer New Advances Transform Treatment of Prostate Cancer

The way we treat prostate cancer has changed dramatically in recent years. Advances in MRI imaging have undoubtedly contributed to this change, both in terms of […]
June 10, 2022

Bimekizumab Tames Active Ankylosing Spondylitis in BE MOBILE 2 Bimekizumab Tames Active Ankylosing Spondylitis in BE MOBILE 2

COPENHAGEN, Denmark — Use of the dual interleukin-17 (IL-17) inhibitor bimekizumab (Bimzelx) was associated with rapid reductions in signs and symptoms of radiographic axial spondyloarthritis, reported […]
June 10, 2022

Division of Hematologic Malignancies 1 (DHM1)

The Division of Hematologic Malignancies 1 (DHM1) manages Investigational New Drug Applications (INDs), New Drug Applications (NDAs), and Biologic Licensing Applications (BLAs) for: Acute leukemias and […]
June 10, 2022

‘My Malpractice Insurance Doubled! I Can’t Afford to Practice’ ‘My Malpractice Insurance Doubled! I Can’t Afford to Practice’

Angela Intili, MD, an ob/gyn, was used to seeing her medical malpractice insurance premium rise slightly every couple of years. But she was shocked by the […]
Prev page
1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950515253545556575859606162636465666768697071727374757677787980818283848586878889909192939495969798991001011021031041051061071081091101111121131141151161171181191201211221231241251261271281291301311321331341351361371381391401411421431441451461471481491501511521531541551561571581591601611621631641651661671681691701711721731741751761771781791801811821831841851861871881891901911921931941951961971981992002012022032042052062072082092102112122132142152162172182192202212222232242252262272282292302312322332342352362372382392402412422432442452462472482492502512522532542552562572582592602612622632642652662672682692702712722732742752762772782792802812822832842852862872882892902912922932942952962972982993003013023033043053063073083093103113123133143153163173183193203213223233243253263273283293303313323333343353363373383393403413423433443453463473483493503513523533543553563573583593603613623633643653663673683693703713723733743753763773783793803813823833843853863873883893903913923933943953963973983994004014024034044054064074084094104114124134144154164174184194204214224234244254264274284294304314324334344354364374384394404414424434444454464474484494504514524534544554564574584594604614624634644654664674684694704714724734744754764774784794804814824834844854864874884894904914924934944954964974984995005015025035045055065075085095105115125135145155165175185195205215225235245255265275285295305315325335345355365375385395405415425435445455465475485495505515525535545555565575585595605615625635645655665675685695705715725735745755765775785795805815825835845855865875885895905915925935945955965975985996006016026036046056066076086096106116126136146156166176186196206216226236246256266276286296306316326336346356366376386396406416426436446456466476486496506516526536546556566576586596606616626636646656666676686696706716726736746756766776786796806816826836846856866876886896906916926936946956966976986997007017027037047057067077087097107117127137147157167177187197207217227237247257267277287297307317327337347357367377387397407417427437447457467477487497507517527537547557567577587597607617627637647657667677687697707717727737747757767777787797807817827837847857867877887897907917927937947957967977987998008018028038048058068078088098108118128138148158168178188198208218228238248258268278288298308318328338348358368378388398408418428438448458468478488498508518528538548558568578588598608618628638648658668678688698708718728738748758768778788798808818828838848858868878888898908918928938948958968978988999009019029039049059069079089099109119129139149159169179189199209219229239249259269279289299309319329339349359369379389399409419429439449459469479489499509519529539549559569579589599609619629639649659669679689699709719729739749759769779789799809819829839849859869879889899909919929939949959969979989991000100110021003100410051006100710081009101010111012101310141015101610171018101910201021102210231024102510261027102810291030103110321033103410351036103710381039104010411042104310441045104610471048104910501051105210531054105510561057105810591060106110621063106410651066106710681069107010711072107310741075107610771078107910801081108210831084108510861087108810891090109110921093109410951096109710981099
Next page
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0